Risk Assessment in Animal Biosafety - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Risk Assessment in Animal Biosafety

Description:

Personal Protective Equipment/Clothing. Engineering Controls/Safety Devices ... Protective Clothing. Gowns, 2 pair of gloves, booties, face protection, ... – PowerPoint PPT presentation

Number of Views:380
Avg rating:3.0/5.0
Slides: 25
Provided by: benfo
Category:

less

Transcript and Presenter's Notes

Title: Risk Assessment in Animal Biosafety


1
Risk Assessment in Animal Biosafety
  • Risk Assessment Factors
  • Pathogen/agent
  • Animal Model (species)
  • Procedures
  • Proposed manipulations
  • Assigned safe work practices

2
Risk Assessment in Animal Biosafety
  • Risk Assessment Factors
  • Personnel
  • Protective Equipment
  • Personal Protective Equipment/Clothing
  • Engineering Controls/Safety Devices
  • Place/Facility for proposed research

3
Risk Assessment in Animal Biosafety
  • Species
  • Natural infections
  • Unpredictable - physical hazards
  • Bites/scratches/splashes
  • Permissive species
  • Immune system of animal
  • Shedding (urine, feces, sputum)
  • Data? Transmission between cage mates? Between
    cages within room?

4
Risk Assessment Process
  • Prior to initiation of work
  • Principal Investigator submits written risk
    assessment
  • Written proposal
  • Registration Form
  • Submitted to the IBC/IACUC/Biosafety Office

5
Committee Risk Assessment
  • Questions/clarification
  • Has PI started w/ Risk Group? Worked towards
    Biosafety Level?
  • Verify that PI has identified
  • Risks involved
  • Routes of exposure (nature/ lab settings)
  • Signs/symptoms of infection
  • Potential for shedding from animals
  • At risk personnel (those contraindicated from
    work)
  • Any special medical surveillance requirements
  • Serum banking, immunizations, screening/evaluation

6
Committee Risk Assessment
  • Questions/clarification
  • Verify that PI has Selected the Appropriate
  • BSL
  • Work Practices
  • PPE
  • Containment Equipment
  • To maximize protection of staff
  • Does Facility meet requirements for BSL selected?

7
Risk Assessment Proposed Procedures
  • Manipulations planned with the animal
  • Blood collection
  • Tissue harvesting/necropsy
  • Aerosols, splash risk
  • Sharps
  • Genetic manipulation

8
Working Safely with Sharps
9
Risk Assessment - Personnel
  • Immune status of host
  • Altered competency suppression (disease,
    therapy)
  • Experience/Training WITH
  • Agent
  • Animals
  • Procedures
  • Equipment
  • Facility
  • Safety Record/Attitude

10
Risk Assessment
  • Ensure that the PIs group is involved in
    development of the SOP!
  • Take ownership

11
Risk Assessment Equipment
  • Cages/housing
  • Open
  • Static, MI (Filtration Efficiency)
  • Ventilated Cage Racks w/ HEPA filters
  • PPE
  • Coat, gown, jump suits, full clothes
    change/shower
  • Masks, face protection, Respirators

12
Handling Microisolator Cages
13
Risk Assessment Facility
  • Conformity w/
  • ABSL-1, ABSL-2, and ABSL-3 Facilities
  • Compliance with pertinent
  • Guidelines
  • Regulations
  • Standards
  • Enhanced Facilities

14
Risk Assessment - Process
  • Professional Judgment Required
  • Expertise
  • IACUC
  • Animal model, animal care and use, animal
    regulations
  • IBC/BSO
  • Agent, exposure routes, med. Surveillance,
    facility design, equipment use/certification
  • Principal Investigator
  • Disease under study, scientific aim, lab
    techniques

15
Risk Assessment - Process
  • After review of Risk Assessment Factors
  • Select most appropriate BSL
  • PPE
  • Work Practices
  • Engineering Controls
  • Facility Controls
  • SOPs prepared and approved
  • Clearance for each researcher/animal handler
  • Written Emergency Response Plans

16
Risk Assessment Process
  • When you dont have all the answers?
  • Be Cautious/Conservative
  • RA is evolving/dynamic process
  • Change as info comes in
  • Communicate RA and RM decisions to all involved

17
LCMV Risk Assessment Example
  • National Risk Group Classification
  • RG3 neurotropic strains, RG2 non-neurotropic
    strains
  • Previous LAI via airborne route
  • Shedding from animal (urine)
  • Clone 13 (persistent shedding)
  • Environmental stability (survives for weeks in
    animal waste)

18
LCMV Risk Assessment Example
  • Use of sharps
  • Inoculations, bleeds, necropsies
  • Transport of tissues, infected cells, virus
  • Protective Clothing
  • Gowns, 2 pair of gloves, booties, face
    protection, Respiratory Protection
  • Protective Equipment
  • Microisolator cages, biosafety cabinets
  • Place ABSL-3 facility

19
Case Study ExampleABSL-2 rDNA Protocol
Vaccinia Virus
  • Location A
  • Registration(s)
  • IACUC
  • IBC
  • Location B
  • Registration(s)
  • IACUC
  • IBC
  • ARC Haz. Agent Form
  • EHS RTUIA-Animals
  • State Human Pathogen registration

20
Case Study ExampleABSL-2 rDNA Vaccinia Virus
  • Location A
  • Review of Training
  • IACUC Orientation
  • Animal Handling
  • Location B
  • Review of Training
  • IACUC Orientation
  • Animal Handling
  • EHS Classes
  • Biosafety, BBP, Chem
  • Researcher Experience Form

21
Case Study ExampleABSL-2 rDNA Vaccinia Virus
  • Location A
  • Specific SOP created
  • none
  • Location B
  • Specific SOP created
  • Entry, exit, supplies
  • Protective clothing
  • Biosafety cabinet use
  • Safe sharps (devices/use)
  • Decontamination
  • Emergency response

22
Case Study ExampleABSL-2 rDNA Vaccinia Virus
  • Location A
  • Additional Requirements
  • Medical Surveillance
  • Health history form
  • Location B
  • Additional Requirements
  • Medical Surveillance
  • Health history form
  • Vaccinia immunization consult
  • Employee Health review

23
Case Study ExampleABSL-2 rDNA Vaccinia Virus
  • Location A
  • Training/Inspection
  • Facility orientation
  • Location B
  • Training/Inspection
  • Facility orientation
  • State DPH Inspection
  • ARC/EHS/VC start-up meeting w/ researcher
  • Researcher work practice observation

24
Case Study ExampleABSL-2 rDNA Vaccinia Virus
  • Location A
  • Implementation
  • Vaccinia needlestick
  • No incident report
  • Vaccinia LAI and bacterial sepsis
  • Hospitalization
  • Report to State DPH
  • Report to NIH OBA (significant incident/illness)
  • Location B
  • Implementation
  • No incidents to date
Write a Comment
User Comments (0)
About PowerShow.com